Global Nuclear Medicine/Radiopharmaceuticals Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026
Table of Contents1 Study Coverage
1.1 Nuclear Medicine/Radiopharmaceuticals Product Introduction
1.2 Market by Type
1.2.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by Type
1.2.2 Diagnostic
1.2.3 Therapeutic
1.3 Market by Application
1.3.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by Application
1.3.2 Oncology
1.3.3 Thyroid
1.3.4 Cardiology
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size Estimates and Forecasts
2.1.1 Global Nuclear Medicine/Radiopharmaceuticals Revenue 2015-2026
2.1.2 Global Nuclear Medicine/Radiopharmaceuticals Sales 2015-2026
2.2 Nuclear Medicine/Radiopharmaceuticals Market Size by Region: 2020 Versus 2026
2.3 Nuclear Medicine/Radiopharmaceuticals Sales by Region (2015-2026)
2.3.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Region: 2015-2020
2.3.2 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Region (2021-2026)
2.3.3 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region (2015-2026)
2.4 Nuclear Medicine/Radiopharmaceuticals Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Region: 2015-2020
2.4.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Region (2021-2026)
2.4.3 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region (2015-2026)
3 Global Nuclear Medicine/Radiopharmaceuticals by Manufacturers
3.1 Global Top Nuclear Medicine/Radiopharmaceuticals Manufacturers by Sales
3.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturer (2015-2020)
3.1.2 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Manufacturer (2015-2019)
3.2 Global Top Nuclear Medicine/Radiopharmaceuticals Manufacturers by Revenue
3.2.1 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturer (2015-2020)
3.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Manufacturer (2015-2020)
3.3 Global Nuclear Medicine/Radiopharmaceuticals Price by Manufacturer (2015-2020)
3.4 Competitive Landscape
3.4.1 Key Nuclear Medicine/Radiopharmaceuticals Manufacturers Covered: Ranking by Revenue
3.4.2 Global Nuclear Medicine/Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI) & (2015-2020)
3.4.3 Global Nuclear Medicine/Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Nuclear Medicine/Radiopharmaceuticals Manufacturing Base Distribution, Product Type
3.5.1 Nuclear Medicine/Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Nuclear Medicine/Radiopharmaceuticals Product Type
3.5.3 Date of International Manufacturers Enter into Nuclear Medicine/Radiopharmaceuticals Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 China Isotope & Radiation
4.1.1 China Isotope & Radiation Corporation Information
4.1.2 China Isotope & Radiation Description, Business Overview
4.1.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Products Offered
4.1.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
4.1.5 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Revenue by Product
4.1.6 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Revenue by Application
4.1.7 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Revenue by Geographic Area
4.1.8 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Revenue by Sales Channel
4.1.9 China Isotope & Radiation Recent Development
4.2 Dongcheng
4.2.1 Dongcheng Corporation Information
4.2.2 Dongcheng Description, Business Overview
4.2.3 Dongcheng Nuclear Medicine/Radiopharmaceuticals Products Offered
4.2.4 Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
4.2.5 Dongcheng Nuclear Medicine/Radiopharmaceuticals Revenue by Product
4.2.6 Dongcheng Nuclear Medicine/Radiopharmaceuticals Revenue by Application
4.2.7 Dongcheng Nuclear Medicine/Radiopharmaceuticals Revenue by Geographic Area
4.2.8 Dongcheng Nuclear Medicine/Radiopharmaceuticals Revenue by Sales Channel
4.2.9 Dongcheng Recent Development
4.3 Jaco
4.3.1 Jaco Corporation Information
4.3.2 Jaco Description, Business Overview
4.3.3 Jaco Nuclear Medicine/Radiopharmaceuticals Products Offered
4.3.4 Jaco Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
4.3.5 Jaco Nuclear Medicine/Radiopharmaceuticals Revenue by Product
4.3.6 Jaco Nuclear Medicine/Radiopharmaceuticals Revenue by Application
4.3.7 Jaco Nuclear Medicine/Radiopharmaceuticals Revenue by Geographic Area
4.3.8 Jaco Nuclear Medicine/Radiopharmaceuticals Revenue by Sales Channel
4.3.9 Jaco Recent Development
4.4 Ciaeriar
4.4.1 Ciaeriar Corporation Information
4.4.2 Ciaeriar Description, Business Overview
4.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Products Offered
4.4.4 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
4.4.5 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Revenue by Product
4.4.6 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Revenue by Application
4.4.7 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Revenue by Geographic Area
4.4.8 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Revenue by Sales Channel
4.4.9 Ciaeriar Recent Development
4.5 Advanced Molecular-imaging Solution
4.5.1 Advanced Molecular-imaging Solution Corporation Information
4.5.2 Advanced Molecular-imaging Solution Description, Business Overview
4.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Products Offered
4.5.4 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
4.5.5 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Revenue by Product
4.5.6 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Revenue by Application
4.5.7 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Revenue by Geographic Area
4.5.8 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Revenue by Sales Channel
4.5.9 Advanced Molecular-imaging Solution Recent Development
4.6 Shanghai Atom Kexing
4.6.1 Shanghai Atom Kexing Corporation Information
4.6.2 Shanghai Atom Kexing Description, Business Overview
4.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Products Offered
4.6.4 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
4.6.5 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Revenue by Product
4.6.6 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Revenue by Application
4.6.7 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Revenue by Geographic Area
4.6.8 Shanghai Atom Kexing Recent Development
...
5 Breakdown Data by Type
5.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2026)
5.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020)
5.1.2 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Type (2021-2026)
5.1.3 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2026)
5.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Type (2015-2026)
5.2.1 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2015-2020)
5.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Type (2021-2026)
5.2.3 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Type (2015-2026)
5.3 Nuclear Medicine/Radiopharmaceuticals Average Selling Price (ASP) by Type (2015-2026)
6 Breakdown Data by Application
6.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2026)
6.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020)
6.1.2 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Application (2021-2026)
6.1.3 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2026)
6.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Application (2015-2026)
6.2.1 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2015-2020)
6.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Application (2021-2026)
6.2.3 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Application (2015-2026)
6.3 Nuclear Medicine/Radiopharmaceuticals Average Selling Price (ASP) by Application (2015-2026)
7 North America
7.1 North America Nuclear Medicine/Radiopharmaceuticals Market Size YoY Growth 2015-2026
7.2 North America Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Country
7.2.1 North America Nuclear Medicine/Radiopharmaceuticals Sales by Country (2015-2026)
7.2.2 North America Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2015-2026)
7.3 North America Nuclear Medicine/Radiopharmaceuticals Sales by Type
7.4 North America Nuclear Medicine/Radiopharmaceuticals Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Market Size YoY Growth 2015-2026
8.2 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Region
8.2.1 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Region (2015-2026)
8.2.2 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Region (2015-2026)
8.3 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Type
8.4 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Application
9 Europe
9.1 Europe Nuclear Medicine/Radiopharmaceuticals Market Size YoY Growth 2015-2026
9.2 Europe Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Country
9.2.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales by Country (2015-2026)
9.2.2 Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2015-2026)
9.3 Europe Nuclear Medicine/Radiopharmaceuticals Sales by Type
9.4 Europe Nuclear Medicine/Radiopharmaceuticals Sales by Application
10 Latin America
10.1 Latin America Nuclear Medicine/Radiopharmaceuticals Market Size YoY Growth 2015-2026
10.2 Latin America Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Country
10.2.1 Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Country (2015-2026)
10.2.2 Latin America Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2015-2026)
10.3 Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Type
10.4 Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures by Country
11.2.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Country (2015-2026)
11.2.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2015-2026)
11.3 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Type
11.4 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Nuclear Medicine/Radiopharmaceuticals Supply Chain Analysis
12.2 Nuclear Medicine/Radiopharmaceuticals Key Raw Materials and Upstream Suppliers
12.3 Nuclear Medicine/Radiopharmaceuticals Clients Analysis
12.4 Nuclear Medicine/Radiopharmaceuticals Sales Channel and Sales Model Analysis
12.4.1 Nuclear Medicine/Radiopharmaceuticals Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Nuclear Medicine/Radiopharmaceuticals Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Nuclear Medicine/Radiopharmaceuticals Distributors
13 Market Dynamics
13.1 Nuclear Medicine/Radiopharmaceuticals Market Drivers
13.2 Nuclear Medicine/Radiopharmaceuticals Market Opportunities
13.3 Nuclear Medicine/Radiopharmaceuticals Market Challenges
13.4 Nuclear Medicine/Radiopharmaceuticals Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of TablesTable 1. Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 2. Major Manufacturers of Diagnostic
Table 3. Major Manufacturers of Therapeutic
Table 4. Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 5. Global Nuclear Medicine/Radiopharmaceuticals Market Size by Region (US$ Million): 2020 VS 2026
Table 6. Global Nuclear Medicine/Radiopharmaceuticals Sales by Region (2015-2020) & (K Units)
Table 7. Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Region (2021-2026) & (K Units)
Table 8. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Region (2015-2020) & (US$ Million)
Table 9. Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Region (2021-2026) & (US$ Million)
Table 10. Global Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturer (2015-2020) & (K Units)
Table 11. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Manufacturer (2015-2020)
Table 12. Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturer (2015-2020) & (US$ Million)
Table 13. Nuclear Medicine/Radiopharmaceuticals Revenue Share by Manufacturer (2015-2020)
Table 14. Key Manufacturers Nuclear Medicine/Radiopharmaceuticals Price (2015-2020) & (USD/Unit)
Table 15. Ranking of Global Top Nuclear Medicine/Radiopharmaceuticals Manufacturers by Revenue (US$ Million) in 2019
Table 16. Global Nuclear Medicine/Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI) & (2015-2020)
Table 17. Global Nuclear Medicine/Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclear Medicine/Radiopharmaceuticals as of 2019)
Table 18. Nuclear Medicine/Radiopharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Nuclear Medicine/Radiopharmaceuticals Product Type
Table 20. Date of International Manufacturers Enter into Nuclear Medicine/Radiopharmaceuticals Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. China Isotope & Radiation Corporation Information
Table 23. China Isotope & Radiation Description and Business Overview
Table 24. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 25. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Product
Table 26. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 27. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 28. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 29. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) and Market Share by Sales Channel
Table 30. China Isotope & Radiation Recent Development
Table 31. Dongcheng Corporation Information
Table 32. Dongcheng Description and Business Overview
Table 33. Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 34. Dongcheng Nuclear Medicine/Radiopharmaceuticals Product
Table 35. Dongcheng Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 36. Dongcheng Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 37. Dongcheng Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 38. Dongcheng Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) and Market Share by Sales Channel
Table 39. Dongcheng Recent Development
Table 40. Jaco Corporation Information
Table 41. Jaco Description and Business Overview
Table 42. Jaco Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 43. Jaco Nuclear Medicine/Radiopharmaceuticals Product
Table 44. Jaco Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 45. Jaco Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 46. Jaco Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 47. Jaco Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) and Market Share by Sales Channel
Table 48. Jaco Recent Development
Table 49. Ciaeriar Corporation Information
Table 50. Ciaeriar Description and Business Overview
Table 51. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 52. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Product
Table 53. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 54. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 55. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 56. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) and Market Share by Sales Channel
Table 57. Ciaeriar Recent Development
Table 58. Advanced Molecular-imaging Solution Corporation Information
Table 59. Advanced Molecular-imaging Solution Description and Business Overview
Table 60. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Product
Table 62. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 63. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 64. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 65. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) and Market Share by Sales Channel
Table 66. Advanced Molecular-imaging Solution Recent Development
Table 67. Shanghai Atom Kexing Corporation Information
Table 68. Shanghai Atom Kexing Description and Business Overview
Table 69. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 70. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Product
Table 71. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 72. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 73. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 74. Shanghai Atom Kexing Recent Development
Table 75. Global Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020) & (K Units)
Table 76. Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Type (2021-2026) & (K Units)
Table 77. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2015-2020) & (US$ Million)
Table 78. Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Type (2021-2026) & (US$ Million)
Table 79. Global Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020) & (K Units)
Table 80. Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Application (2021-2026) & (K Units)
Table 81. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2015-2020) & (US$ Million)
Table 82. Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Application (2021-2026) & (US$ Million)
Table 83. North America Nuclear Medicine/Radiopharmaceuticals Sales by Country (2015-2020) & (K Units)
Table 84. North America Nuclear Medicine/Radiopharmaceuticals Sales by Country (2021-2026) & (K Units)
Table 85. North America Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2015-2020) & (US$ Million)
Table 86. North America Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2021-2026) & (US$ Million)
Table 87. North America Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020) & (K Units)
Table 88. North America Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020) & (K Units)
Table 89. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Region (2015-2020) & (K Units)
Table 90. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Region (2021-2026) & (K Units)
Table 91. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Region (2015-2026) & (US$ Million)
Table 92. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Region (2021-2026) & (US$ Million)
Table 93. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020) & (K Units)
Table 94. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020) & (K Units)
Table 95. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Country (2015-2020) & (K Units)
Table 96. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Country (2021-2026) & (K Units)
Table 97. Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2015-2020) & (US$ Million)
Table 98. Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2021-2026) & (US$ Million)
Table 99. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020) & (K Units)
Table 100. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020) & (K Units)
Table 101. Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Country (2015-2020) & (K Units)
Table 102. Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Country (2021-2026) & (K Units)
Table 103. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2015-2020) & (US$ Million)
Table 104. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2021-2026) & (US$ Million)
Table 105. Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020) & (K Units)
Table 106. Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020) & (K Units)
Table 107. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Country (2015-2020) & (K Units)
Table 108. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Country (2021-2026) & (K Units)
Table 109. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2015-2020) & (US$ Million)
Table 110. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2021-2026) & (US$ Million)
Table 111. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020) & (K Units)
Table 112. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020) & (K Units)
Table 113. Nuclear Medicine/Radiopharmaceuticals Key Raw Materials, Industry Status and Trend
Table 114. Nuclear Medicine/Radiopharmaceuticals Key Raw Materials and Upstream Suppliers
Table 115. Nuclear Medicine/Radiopharmaceuticals Clients Status and Trend
Table 116. Nuclear Medicine/Radiopharmaceuticals Typical Clients
Table 117. Nuclear Medicine/Radiopharmaceuticals Distributors
Table 118. Key Drivers: Impact Analysis (2021-2026)
Table 119. Nuclear Medicine/Radiopharmaceuticals Market Drivers
Table 120. Nuclear Medicine/Radiopharmaceuticals Market Opportunities
Table 121. Nuclear Medicine/Radiopharmaceuticals Market Challenges
Table 122. Nuclear Medicine/Radiopharmaceuticals Market Restraints
Table 123. Nuclear Medicine/Radiopharmaceuticals Porter's Five Forces Analysis
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of FiguresFigure 1. Nuclear Medicine/Radiopharmaceuticals Product Picture
Figure 2. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2020 & 2026
Figure 3. Diagnostic Product Picture
Figure 4. Therapeutic Product Picture
Figure 5. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2020 & 2026
Figure 6. Oncology Examples
Figure 7. Thyroid Examples
Figure 8. Cardiology Examples
Figure 9. Nuclear Medicine/Radiopharmaceuticals Report Years Considered
Figure 10. Global Nuclear Medicine/Radiopharmaceuticals Market Size, (US$ Million), 2015 VS 2020 VS 2026
Figure 11. Global Nuclear Medicine/Radiopharmaceuticals Market Size 2015-2026 (US$ Million)
Figure 12. Global Nuclear Medicine/Radiopharmaceuticals Sales 2015-2026 (K Units)
Figure 13. Global Nuclear Medicine/Radiopharmaceuticals Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share Forecast by Region (2015-2026)
Figure 15. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region (2015-2026)
Figure 16. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Manufacturer in 2019
Figure 17. Nuclear Medicine/Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share Forecast by Type (2015-2026)
Figure 19. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share Forecast by Type (2015-2026)
Figure 20. Nuclear Medicine/Radiopharmaceuticals Average Selling Price (ASP) by Type (2015-2020) & (USD/Unit)
Figure 21. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share Forecast by Application (2015-2026)
Figure 22. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share Forecast by Application (2015-2026)
Figure 23. Nuclear Medicine/Radiopharmaceuticals Average Selling Price (ASP) by Application (2015-2020) & (USD/Unit)
Figure 24. North America Nuclear Medicine/Radiopharmaceuticals Revenue 2015-2026 (US$ Million)
Figure 25. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Figure 26. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Figure 27. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue 2015-2026 (US$ Million)
Figure 28. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region (2015-2026)
Figure 29. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region (2015-2026)
Figure 30. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Figure 31. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Figure 32. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2015-2026 (US$ Million)
Figure 33. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2015-2026)
Figure 34. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2015-2026)
Figure 35. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Figure 36. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Figure 37. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2015-2026 (US$ Million)
Figure 38. Latin America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2015-2026)
Figure 39. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Figure 40. Latin America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Figure 41. Latin America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Figure 42. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2015-2026 (US$ Million)
Figure 43. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2015-2026)
Figure 44. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2015-2026)
Figure 45. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Figure 46. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Figure 47. Nuclear Medicine/Radiopharmaceuticals Supply Chain (Upstream and Downstream Market)
Figure 48. Global Production Market Share of Nuclear Medicine/Radiopharmaceuticals Raw Materials by Region in 2019
Figure 49. Nuclear Medicine/Radiopharmaceuticals Distribution Channels
Figure 50. Global Nuclear Medicine/Radiopharmaceuticals Percentage 2015-2026: Indirect Sales VS Direct Sales
Figure 51. Global Nuclear Medicine/Radiopharmaceuticals Percentage 2015-2026: Online Sales VS Offline Sales
Figure 52. Porter's Five Forces Analysis
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed